Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;4(6):235-45.
doi: 10.1177/2042098613500689.

Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients

Affiliations

Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients

Clare V Bostock et al. Ther Adv Drug Saf. 2013 Dec.

Abstract

Objective: To compare associations between four measures of anticholinergic exposure (anticholinergic risk scale, ARS; anticholinergic drug burden, DBAC; number and use versus no use of anticholinergic drugs), Barthel Index (BI, physical function) and Abbreviated Mental Test (AMT, cognitive function) on admission in older hospitalized patients.

Methods: Prospective observational study of a consecutive series of 271 older patients (age 83 ± 7 years) from community-dwelling and institutionalized settings, admitted to an acute geriatric admission unit between 28 September 2011 and 18 December 2011. The main outcome measures were BI quartiles (primary outcome) and AMT (secondary outcome) on admission.

Results: Anticholinergic prevalence was 47%. Multinomial logistic regression showed higher DBAC was associated with a greater risk of being in the lower BI quartiles versus highest BI quartile (Q4). This risk was significant for Q3 (p = 0.04) and Q2 (p = 0.02) but not for Q1 (p = 0.06). A greater number of anticholinergic drugs was associated with a higher risk of being in Q2 (p = 0.02). This risk was not significant for either Q3 (p = 0.10) or Q1 (p = 0.06). No significant associations were observed either with use of anticholinergic medication or with ARS and BI quartiles. AMT did not show independent associations with any of the four measures of anticholinergic exposure.

Conclusion: In older hospitalized patients, DBAC and some crude measures of anticholinergic exposure, but not ARS, showed independent associations with lower BI, but not AMT. These results highlight differences between various measures of anticholinergic drug exposure when studying their associations with functional status.

Keywords: Aged; Anticholinergic Risk Scale; Barthel Index; Drug Burden Index; cholinergic antagonists; drug toxicity; frail elderly; muscarinic antagonists.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: All authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Frequency distributions of: (a) Abbreviated Mental Test (AMT) score; (b) Barthel Index; (c) Anticholinergic Risk Scale (ARS); (d) Anticholinergic Drug Burden (DBAC); (e) number of anticholinergic medications.

Similar articles

Cited by

References

    1. Bostock C., Soiza R., Mangoni A. (2010) Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people. Expert Rev Clin Pharmacol 3: 441–452 - PubMed
    1. British Medical Association and Royal Pharmaceutical Society of Great Britain (2011) British National Formulary, 62nd edition. London: RPS Publishing
    1. Cao Y., Mager D., Simonsick E., Hilmer S., Ling S., Windham B., et al. . (2008) Physical and cognitive performances and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 83: 422–429 - PubMed
    1. Casarosa P., Keichle T., Sieger P., Pieper M., Ganter F. (2010) The constitutive activity of the human muscarinic M3 receptor unmasks differences in the pharmacology of anticholinergics. J Pharmacol Exp Ther 333: 201–209 - PubMed
    1. de Groot V., Beckerman H., Lankhorst G., Bouter L. (2003) How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 56: 221–229 - PubMed

LinkOut - more resources